Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the liver microenvironment. Experiments will utilize animal models, cell culture including induced pluripotent stem cells, and human patient samples. Required Qualifications: Applicants should hold a PhD
-
Leukemia DC15: Novel preclinically-validated GATA3 inhibitor/degrader as a therapy for T-cell Acute Lymphoblastic Leukemia DC16: Targeting Metabolic Pathways in Leukemic Stem Cells for AML Treatment
-
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
Innovation Platform for BioPolymers, the CIRM funded Stem Cell Institute, NSF Quantum Foundry, and the Materials Research Laboratory supported by 7 consecutive NSF Materials Research Science & Engineering
-
of scientific publications in relevant fields. Experience with models of myopathies or inflammation. Familiarity with stem cell-derived muscle models or 3D culture systems (including physiological
-
and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work experience or community service has prepared them to contribute to our
-
induced pluripotent stem cells (iPSCs); differentiation of pluripotent cells into neuronal lineages; genome engineering using CRISPR/Cas9; molecular biology and biochemistry laboratory techniques (e.g
-
release of cell therapy products. At UCI, the cGMP facility will enable clinical trials of cell therapeutics, including stem cell populations and bone marrow transplantation, as well as Chimeric Antigen
-
stem cells (satellite cells) can be guided by anatomical and environmental signals to generate muscle fibers that are more resistant to disease. Using a unique collection of genetically engineered
-
Plan: The Researcher shall be involved in all the tasks of the research project entitled “Dissecting the molecular mechanisms of X-chromosome inactivation using human embryonic stem cells”, with